EP0580758A4 - Anti-human immunodeficiency virus recombinant antibodies. - Google Patents

Anti-human immunodeficiency virus recombinant antibodies.

Info

Publication number
EP0580758A4
EP0580758A4 EP92911196A EP92911196A EP0580758A4 EP 0580758 A4 EP0580758 A4 EP 0580758A4 EP 92911196 A EP92911196 A EP 92911196A EP 92911196 A EP92911196 A EP 92911196A EP 0580758 A4 EP0580758 A4 EP 0580758A4
Authority
EP
European Patent Office
Prior art keywords
immunodeficiency virus
human immunodeficiency
recombinant antibodies
virus recombinant
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP92911196A
Other languages
German (de)
French (fr)
Other versions
EP0580758A1 (en
Inventor
Bona Constantin
Zaghouani E Th Street Habib
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Icahn School of Medicine at Mount Sinai
Original Assignee
Mount Sinai School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mount Sinai School of Medicine filed Critical Mount Sinai School of Medicine
Publication of EP0580758A1 publication Critical patent/EP0580758A1/en
Publication of EP0580758A4 publication Critical patent/EP0580758A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
EP92911196A 1991-04-18 1992-04-10 Anti-human immunodeficiency virus recombinant antibodies. Withdrawn EP0580758A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68737691A 1991-04-18 1991-04-18
US687376 1991-04-18

Publications (2)

Publication Number Publication Date
EP0580758A1 EP0580758A1 (en) 1994-02-02
EP0580758A4 true EP0580758A4 (en) 1995-04-05

Family

ID=24760226

Family Applications (1)

Application Number Title Priority Date Filing Date
EP92911196A Withdrawn EP0580758A4 (en) 1991-04-18 1992-04-10 Anti-human immunodeficiency virus recombinant antibodies.

Country Status (6)

Country Link
EP (1) EP0580758A4 (en)
JP (1) JPH06506947A (en)
AU (1) AU672580B2 (en)
CA (1) CA2107329C (en)
IL (1) IL101602A (en)
WO (1) WO1992018540A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3355351B2 (en) * 1989-02-24 2002-12-09 ユーロジェン・ホールディング・ソシエテ・アノニム Genetically engineered immunoglobulins
US5969109A (en) * 1990-02-28 1999-10-19 Bona; Constantin Chimeric antibodies comprising antigen binding sites and B and T cell epitopes
GB0102145D0 (en) * 2001-01-26 2001-03-14 Scancell Ltd Substances

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1338518C (en) * 1987-09-23 1996-08-13 Joyce M. Zarling Antibody heteroconjugates for the killing of hiv-infected cells
JPH07504802A (en) * 1992-03-17 1995-06-01 ノバルティス　アクチェンゲゼルシャフト genetically engineered antibodies
ES2053413T3 (en) * 1992-05-14 1997-11-16 Polymun Scient Immunbio Forsch PEPTIDES INDUCING ANTIBODIES THAT NEUTRALIZE GENETICALLY DIVERGENT HIV-1 ISOLATES.

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
H. KUZU ET AL.: "In vivo priming of NP-specific CTL with self immunoglobulin bearing an influenza virus epitope.", THE FASEB JOURNAL, vol. 6, no. 5, 28 February 1992 (1992-02-28), BETHESDA MD, USA, pages A1968 *
H. ZAQHOUANI ET AL.: "Recombinant immunoglobulin gene encoding a viral CTL epitope mediates cell killing by specific cytotoxic T lymphocytes.", THE FASEB JOURNAL, vol. 5, no. 5, 15 March 1991 (1991-03-15), BETHESDA MD, USA, pages A1334 *
M. SOLLAZZO ET AL.: "Expression of an exogenous peptide epitope genetically engineered in the variable domain of an immunoglobulin: implications for antibody and peptide folding.", PROTEIN ENGINEERING, vol. 4, no. 2, December 1990 (1990-12-01), OXFORD, GB, pages 215 - 220 *
P. PEREZ ET AL.: "Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibody.", NATURE, vol. 316, 25 July 1985 (1985-07-25), LONDON, GB, pages 354 - 356 *
See also references of WO9218540A1 *

Also Published As

Publication number Publication date
IL101602A (en) 1996-10-31
AU672580B2 (en) 1996-10-10
CA2107329C (en) 1999-04-27
AU1891992A (en) 1992-11-17
IL101602A0 (en) 1992-12-30
JPH06506947A (en) 1994-08-04
EP0580758A1 (en) 1994-02-02
CA2107329A1 (en) 1992-10-19
WO1992018540A1 (en) 1992-10-29

Similar Documents

Publication Publication Date Title
GR3035575T3 (en) HLA-restricted hepatitis B virus CTL epitopes.
EP0627932A4 (en) Novel antibody construct.
GB9507420D0 (en) Recombinant humanized anti-cytomegalovirus antibodies
ATA257190A (en) VIRAL POLYPEPTIDE
GB9415380D0 (en) Recombinant antibodies specific for tnf-
EP0676966A4 (en) Antibodies directed against binding-associated epitopes.
HU912526D0 (en) Recombinant marek-type disease virus
AU635996B2 (en) Recombinant human anti-cd18 antibodies
EP0438312A3 (en) Recombinant human anti-cd18 antibodies
AU2683792A (en) Peptide based hepatitis c virus immunoassays
AU2370592A (en) Epitopes of the env protein of the hepatitis c virus
AU3509693A (en) A recombinant hepatitis C virus polypeptide
EP0506523A3 (en) Monoclonal antibodies
EP0469897A3 (en) Engineered antibodies
KR950700933A (en) Synthetic polypeptides derived from the HIV envelope glycoprotein
EP0580758A4 (en) Anti-human immunodeficiency virus recombinant antibodies.
EP0600000A4 (en) Hepatitis c assay utilizing recombinant antigens from ns5 region.
EP0637631A3 (en) Highly efficient expression of a polypeptide containing a modified preS1 region of the major hepatitis B virus antigen.
ZA926441B (en) HLA-restricted hepatitis B virus CTL epitopes.
ZA898357B (en) An anti-human immunodeficiency virus composition
GB9106568D0 (en) Recombinant antigen
ITFI920071A1 (en) PROTEIN RECOMBINANT ANTIGENS WITH INCREASED IMMUNOGENICITY CONTAINING THE PEPTIDE REPRESENTED BY THE VQGEESNDK SEQUENCE
AU8225891A (en) Anti-human immunodeficiency virus agent
IE892694L (en) Monoclonal antibody against hiv virus
ZA912581B (en) Hepatitis c virus epitopes

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19931007

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19950215

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE

17Q First examination report despatched

Effective date: 19970321

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19990423